4th Quarter - Report

PARRY, ROMANI, DECONCINI & SYMMS for MEDICIS PHARMACEUTICAL CORPORATION

Firm
Client
Income
$36,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Oppose bills that prohibit brand name drug companies from settling patent litigation with generic drug companies and for other purposes. S. 27, Preserve Access to Affordable Generics Act and H.R. 3995, Protecting Consumer Access to Generic Drugs Act of 2012.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 27 (112th), H.R. 3995 (112th)

Health Issues HCR

Assist company in obtaining exception to FDA regulations concerning chlorofluorocarbons (CFCs) to maintain patient access to important medication.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.